Email This Article

Headlines & Perspectives
Amag Soars as FDA Plans Quick Drug Review
By Elizabeth Trotta
11/13/08 - 10:45 AM EST
The stock jumps 70% after the Food and Drug Administration says it will give a speedy review to the company's latest submission for an iron-replacement therapy.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,328.89 1,102.47 2,211.69 35.46
Oil *
73.88
UP
20.63
UP
6.40
UP
31.64
UP
0.59
10 Yr
3.55%
SPDR Gold
108.95
+0.20%
+0.58%
+1.45%
+1.69%
Data delayed 20 minutes

More From TheStreet

Latest Headlines

Brokerage Partners